跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Astymin-3 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Astymin-3
Approved
STANDARD
Astymin-3
Tablets (India) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
75123d71a2b56e20
Company
Tablets (India) Ltd.
Type
Standard
Approval Details
Approval Id
75123d71a2b56e20
Drug Approval Philippines Name
Astymin-3
Product Name
Astymin-3
Registration Number
DRP-3112
Brand Name
Astymin-3
Generic Name
Amino Acids + Sorbitol
Dosage Form
9.12% in 5% solution Solution for IV Infusion
Dosage Strength
Formulation: Each mL contains: L-lysine HCL -22.3 mg L-isoleucine -5.5 mg L-leucine -12.3 mg L-threonine -5.4 mg L-phenylalanine -8.7 mg L'histidine HCI H20 -4.0 mg L-arginine HCL -8.0 mg L-tryptophan -1.8 mg L-methionine -7.1 mg Sorbitol -50.0 mg L-valine -6.1 mg Glycine -10.0 mg
Manufacturer
Tablets (India) Ltd.
Importer
Pharma-Surrey International, Inc.
Distributor
Pharma-Surrey International, Inc.
Issuance Date
29 December 2020
Expiry Date
03 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
75123d71a2b56e20
Type
Standard
Back to Philippines FDA Approvals